Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. (INSP) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Inspire Medical Systems, Inc. (INSP), covering cash flow, earnings, and balance sheets.
Inspire Medical Systems, Inc. (INSP) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Inspire Medical Systems, Inc. INSP financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $201.32M | $239.72M | $203.19M | $195.88M |
| Cost of Revenue | $30.71M | $35.99M | $32.40M | $29.84M |
| Gross Profit | $170.61M | $203.73M | $170.79M | $166.04M |
| Gross Profit Ratio | $0.85 | $0.85 | $0.84 | $0.85 |
| R&D Expenses | $27.80M | $30.34M | $26.08M | $28.86M |
| SG&A Expenses | $144.29M | $141.51M | $130.39M | $132.08M |
| Operating Expenses | $172.09M | $171.85M | $156.47M | $160.94M |
| Total Costs & Expenses | $202.80M | $207.83M | $188.87M | $190.79M |
| Interest Income | $0.00 | $5.55M | $5.89M | $5.88M |
| Interest Expense | $0.00 | $22000.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $2.48M | $1.85M | $1.38M |
| EBITDA | -$1.49M | $56.75M | $16.17M | $6.48M |
| EBITDA Ratio | -$0.007 | $0.24 | $0.08 | $0.03 |
| Operating Income | -$1.49M | $31.88M | $14.32M | $5.10M |
| Operating Income Ratio | -$0.007 | $0.13 | $0.07 | $0.03 |
| Other Income/Expenses (Net) | $5.64M | $4.75M | $6.008M | $5.75M |
| Income Before Tax | $4.16M | $36.64M | $20.33M | $10.85M |
| Income Before Tax Ratio | $0.02 | $0.15 | $0.10 | $0.06 |
| Income Tax Expense | $1.17M | $1.41M | $1.83M | $1.05M |
| Net Income | $2.99M | $35.22M | $18.50M | $9.79M |
| Net Income Ratio | $0.01 | $0.15 | $0.09 | $0.05 |
| EPS | $0.10 | $1.18 | $0.62 | $0.33 |
| Diluted EPS | $0.10 | $1.15 | $0.60 | $0.32 |
| Weighted Avg Shares Outstanding | $29.70M | $29.76M | $29.88M | $29.73M |
| Weighted Avg Shares Outstanding (Diluted) | $30.31M | $30.75M | $30.63M | $30.41M |
Over the last four quarters, Inspire Medical Systems, Inc. achieved steady financial progress, growing revenue from $195.88M in Q2 2024 to $201.32M in Q1 2025. Gross profit stayed firm with margins at 85% in Q1 2025 versus 85% in Q2 2024. Operating income totaled -$1.49M in Q1 2025, maintaining a -1% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$1.49M. Net income dropped to $2.99M, with EPS at $0.10. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan